Kevin Hykes is the President and CEO of Augmedics and an accomplished medical device industry executive with 30 years of experience. Prior to joining Augmedics, Mr. Hykes was President and CEO of Bardy Diagnostics, a provider of ambulatory cardiac monitoring and digital health solutions which was acquired by the Hillrom Corporation in August of 2021. Before Bardy Diagnostics, Mr. Hykes served in President and CEO roles at Relievant Medsystems, Metavention, Inc. and Cameron Health. Mr. Hykes also spent over sixteen years at Medtronic, where he held leadership positions in the CRM, Neurostimulation and Cardiac Surgery businesses in the U.S. and Europe. He is currently an Operating Partner with Revival Healthcare Capital and an independent board member at CVRx Inc. (CVRX) and Metavention, Inc. Mr. Hykes received his MBA from Northwestern University and a BBA in Information Systems from the University of Wisconsin.
